Journey Medical CorporationDERMNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P18
Within normal range
vs 2Y Ago
-0.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -152.97% |
| Q2 2025 | 66.74% |
| Q1 2025 | -227.28% |
| Q4 2024 | 292.31% |
| Q3 2024 | 77.65% |
| Q2 2024 | -3.13% |
| Q1 2024 | 69.45% |
| Q4 2023 | -187.64% |
| Q3 2023 | 372.34% |
| Q2 2023 | 515.17% |
| Q1 2023 | 75.08% |
| Q4 2022 | 47.32% |
| Q3 2022 | -120.67% |
| Q2 2022 | -473.30% |
| Q1 2022 | 127.57% |
| Q4 2021 | -145.14% |
| Q3 2021 | 195.48% |
| Q2 2021 | -646.51% |
| Q1 2021 | -73.07% |
| Q4 2020 | 571.90% |
| Q3 2020 | -286.42% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q3 2019 | 90.21% |
| Q2 2019 | 9.42% |
| Q1 2019 | 12.35% |
| Q4 2018 | 41.92% |
| Q3 2018 | -483.88% |
| Q2 2018 | 57.86% |
| Q1 2018 | -73.17% |
| Q4 2017 | 2.23% |
| Q3 2017 | -116.64% |
| Q2 2017 | 40.30% |
| Q1 2017 | -3742.36% |
| Q4 2016 | 103.26% |
| Q3 2016 | 23.79% |
| Q2 2016 | -6.37% |
| Q1 2016 | -81.53% |
| Q4 2015 | 3.64% |
| Q3 2015 | -5.41% |